Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SET pseudogene 21 (abbreviated as SETP21) is classified as a pseudogene, which means it is a segment of DNA that resembles a functional gene but is nonfunctional and does not encode a protein product[5][3][8]. No current evidence supports biological function, disease involvement, or druggability. Pseudogenes may have regulatory roles at the nucleic acid level, but such functions are not established for SETP21. No evidence links SETP21 to therapeutic relevance or known biology beyond its DNA sequence similarity to other SET genes. If you are seeking information about a protein-coding SET family member (e.g., SET nuclear oncogene), please clarify, as this entry is not a conventional target for drugs or biologics[5][3][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SET pseudogene 21 (SETP21).